Overview
Ryan Robetorye is a Hematologist in Phoenix, Arizona. Dr. Robetorye is rated as an Advanced provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Acute Myelomonocytic Leukemia, Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
5777 E Mayo Blvd, Phoenix, AZ 85054
13400 E Shea Blvd, Scottsdale,, AZ 85259
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Palo Verde Hematology Oncology Ltd
Amol Rakkar is a Hematologist and an Oncologist in Phoenix, Arizona. Dr. Rakkar is rated as a Distinguished provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Thrombocytopenia, Deep Vein Thrombosis, Pulmonary Embolism, and Essential Thrombocythemia. Dr. Rakkar is currently accepting new patients.
Ironwood Physicians, PC
Kalyan Mantripragada is a Hematologist in Gilbert, Arizona. Dr. Mantripragada is rated as a Distinguished provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Pulmonary Embolism, Hemochromatosis, Agranulocytosis, Childhood Iron Deficiency Anemia, and Gallbladder Removal.
Ironwood Physicians, PC
Dr. DeRoock joined Ironwood Cancer & Research Centers in 2009 after completing residency in Internal Medicine followed by fellowship in Hematology and Oncology at the University of California at Davis. He is a first-generation Panamanian-American fluent in both English and Spanish. He previously earned his medical degree at the University of Arizona. Dr. DeRoock is board certified in Internal Medicine, Hematology and Medical Oncology. He has been active in developing clinical trials for pancreatic cancer and lymphoma, and has presented his research findings at the American Society of Hematology Annual Meeting as well as the Annual Pan-Pacific Lymphoma Conference. He specializes in all adult cancers and hematologic disorders.Supportive Cancer Care You Can TrustYou can find that team at Ironwood Cancer & Research Centers. With community-based centers strategically located throughout the Metro Phoenix area, Ironwood offers advanced therapies and a multi-disciplinary approach usually associated with large academic centers – but with a personalized touch recognizing the individual needs of the patient.Studies have shown the importance of a multi-disciplinary approach in effectively treating cancer. We spare you time and worry simply by having all the doctors, therapists, and resources you need in one convenient location, eliminating the delays and miscommunication. These collaborative efforts ensure the highest standards of care. Because Ironwood is actively involved in cutting-edge research, you can also benefit from promising new treatments through participation in clinical trials. Dr. Deroock is rated as a Distinguished provider by MediFind in the treatment of Thalassemia. His top areas of expertise are Pulmonary Embolism, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Robetorye isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Robetorye isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Robetorye isDistinguished. Learn about Acute Myelomonocytic Leukemia.
- AnemiaDr. Robetorye isDistinguished. Learn about Anemia.
- Cardiac AmyloidosisDr. Robetorye isDistinguished. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Robetorye isDistinguished. Learn about Cerebral Amyloid Angiopathy.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Robetorye isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Adult Immune ThrombocytopeniaDr. Robetorye isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Robetorye isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Robetorye isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Angioimmunoblastic T-cell LymphomaDr. Robetorye isAdvanced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Robetorye isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Megakaryoblastic LeukemiaDr. Robetorye isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Promyelocytic LeukemiaDr. Robetorye isExperienced. Learn about Acute Promyelocytic Leukemia.
- Alpha ThalassemiaDr. Robetorye isExperienced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Anaplastic Large Cell LymphomaDr. Robetorye isExperienced. Learn about Anaplastic Large Cell Lymphoma.
